Delivery Order SPE2DB20D3103-SPE2DB25FQ3J1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,258.38 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml units, with a contract ceiling value of $2,224.32. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a $1,110.96 delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, indicating the award was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $3,495.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10mL units, with an ultimate completion date of September 15, 2025. This non-set-aside contract was competitively awarded on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dorzolamide-Timolol eye drops (10ml) with a contract ceiling value of $1,318.75. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $10,920 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561308595 Dorzolamide-Timolol eye drops. The firm fixed price order is to provide 10mL bottles of the ophthalmic solution. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order was awarded on June 20, 2023 under an existing DLA pharmaceuticals contract vehicle and runs through June 21, 2023. As a leading provider of...
- The Defense Logistics Agency awarded a delivery order valued at $4,475.58 to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol 2%-0.5% ophthalmic medication in 60-unit quantities. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $144,270 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562174628 Dorzolamide-Timolol eye drops. As the prime contractor, Amerisourcebergen will deliver 10mL bottles of the ophthalmic solution to a facility in Conshohocken, Pennsylvania by September 15, 2023 in support of the Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued under an existing...
- The Defense Logistics Agency awarded a $1,820 delivery order to Amerisourcebergen Drug Corporation for 4561410803 Dorzolamide-Timolol Eye Drops 10ML. The firm fixed price order is for the supply of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania, with performance required from July 5-6, 2023. Amerisourcebergen will serve as the prime contractor, with no major subcontractors indicated. As a component of the Department of Defense, the Defense Logistics Agency...
- The Defense Logistics Agency awarded a $216,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561355000 Dorzolamide-Timolol eye drops. Under this contract, Amerisourcebergen will deliver 10mL bottles of the prescribed ophthalmic solution to a facility in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The contract is a delivery order under an...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3J1Delivery Order
The Defense Logistics Agency awarded a $21,402 delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on September 16, 2025, with completion expected by September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's comprehensive federal contract portfolio demonstrates its capability to deliver a broad spectrum of pharmaceutical products across multiple therapeutic domains, from specialty medications and vaccines to medical devices and diagnostic supplies. This delivery order for ophthalmic medication supports the agency's medical supply requirements and reflects the vendor's ongoing role as a key supplier within the DLA's pharmaceutical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 9/16/25 |